Dopamine Synthesis Capacity Before Onset of Psychosis: A Prospective [ 18 F]-DOPA PET Imaging Study
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: While there is robust evidence of elevated dopamine synthesis capacity once a psychotic disorder has developed, little is known about whether it is altered prior to the first episode of frank illness. The authors addressed this issue by measuring dopamine synthesis capacity in individuals at ultra-high risk of psychosis and then following them to determine their clinical outcome. METHOD: This prospective study included 30 patients who met standard criteria for being at ultra-high risk of psychosis and 29 healthy volunteers. Participants were scanned using [(18)F]6-fluoro-L-dopa positron emission tomography. The ultra-high-risk patients were scanned at presentation and followed up for at least 3 years to determine their clinical outcome. Six patients had comorbid schizotypal personality disorder and were excluded from the analysis (data are provided for comparison). Of the remaining patients, nine developed a psychotic disorder (psychotic transition group) and 15 did not (nontransition group). RESULTS: There was a significant effect of group on striatal dopamine synthesis capacity. The psychotic transition group had greater dopamine synthesis capacity in the striatum (effect size=1.18) and its associative subdivision (effect size=1.24) than did the healthy comparison subjects and showed a positive correlation between dopamine synthesis capacity and symptom severity. Dopamine synthesis capacity was also significantly greater in the psychotic transition group than in the nontransition group. CONCLUSIONS: These findings provide evidence that the onset of frank psychosis is preceded by presynaptic dopaminergic dysfunction. Further research is needed to determine the specificity of elevated dopamine synthesis capacity to particular psychotic disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Dopamine synthesis capacity is greater in individuals who later transition to psychosis than those who do not transition (63),”
From Aberrant Salience, Information Processing, and Dopaminergic Signaling in People at Clinical High Risk for Psychosis (2020) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data
Patlak, C. S., Blasberg, R. G., & Fenstermacher, J. D. (1983) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1983.1 · Cited by 3,567
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
Howes, O. D., & Kapur, S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp006 · Cited by 2,693
Self-citationMapping the Onset of Psychosis: The Comprehensive Assessment of At-Risk Mental States
Yung, A. R., Yung, A. R., Pan Yuen, H., Mcgorry, P. D., Phillips, L. J., Kelly, D., Dell'olio, M., Francey, S. M., Cosgrave, E. M., Killackey, E., et al. (2005) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2005.01714.x · Cited by 2,196
Dopamine in schizophrenia: a review and reconceptualization
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.11.1474 · Cited by 2,018
The primate basal ganglia: Parallel and integrative networks
Haber, S. N. (2003) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2003.10.003 · Cited by 1,479
Hammers, A., Allom, R., Koepp, M. J., Free, S. L., Myers, R., Lemieux, L., Mitchell, T. N., Brooks, D. J., & Duncan, J. S. (2003) · Human Brain Mapping · doi:10.1002/hbm.10123 · Cited by 1,286
Cannon, T. D., Cadenhead, K., Cornblatt, B., Woods, S. W., Addington, J., Walker, E., Seidman, L. J., Perkins, D., Tsuang, M., McGlashan, T., et al. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.3 · Cited by 1,269
Lisman, J. E., Coyle, J. T., Green, R. W., Javitt, D. C., Benes, F. M., Heckers, S., & Grace, A. A. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.02.005 · Cited by 1,010
Elevated Striatal Dopamine Function Linked to Prodromal Signs of Schizophrenia
Howes, O. D., Montgomery, A. J., Asselin, M.-C., Murray, R. M., Valli, I., Tabraham, P., Bramon-Bosch, E., Valmaggia, L., Johns, L., Broome, M., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2008.514 · Cited by 744
Self-citation
Research works printed but not linked: 1
- American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994 American Psychiatric Association Press Washington DC Fourth edition
Cited by
Items 201–300 of 344
Turk, K. W., Flanagan, M. E., Josephson, S., Keene, C. D., Jayadev, S., & Bird, T. D. (2017) · The Cerebellum · doi:10.1007/s12311-017-0882-5 · Cited by 16
Leveraging Basic Science for the Clinic—From Bench to Bedside
Corlett, P. R., & Schoenbaum, G. M. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.3656 · Cited by 16
Masucci, M. D., Lister, A., Corcoran, C. M., Brucato, G., & Girgis, R. R. (2018) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000000806 · Cited by 17
Renaldi, R., Kim, M., Lee, T. H., Kwak, Y. B., Tanra, A. J., & Kwon, J. S. (2019) · Psychiatry Investigation · doi:10.30773/pi.2019.06.20.1 · Cited by 15
Barnby, J. M., Bell, V., Deeley, Q., Mehta, M. A., & Moutoussis, M. (2024) · Nature Mental Health · doi:10.1038/s44220-024-00220-6 · Cited by 16
Early Detection and Intervention in Psychosis
Riecher‐Rössler, A., & McGorry, P. D. (2016) · Key issues in mental health (Online)/Key issues in mental health (Print) · doi:10.1159/000440924 · Cited by 18
Brain Networks Reveal the Effects of Antipsychotic Drugs on Schizophrenia Patients and Controls
Towlson, E. K., Vértes, P. E., Müller, U., & Ahnert, S. E. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00611 · Cited by 18
Frydecka, D., Kotowicz, K., Gawęda, Ł., Prochwicz, K., Kłosowska, J., Rymaszewska, J., Samochowiec, A., Samochowiec, J., Podwalski, P., Pawlak, E., et al. (2020) · European Psychiatry · doi:10.1192/j.eurpsy.2020.103 · Cited by 14
van Hooijdonk, C. F. M., Drukker, M., van de Giessen, E., Booij, J., Selten, J., & van Amelsvoort, T. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102265 · Cited by 16
Prenatal hypoxia alters the early ontogeny of dopamine neurons
Brandon, A., Cui, X., Luan, W., Ali, A. A., Pértile, R. A. N., Alexander, S., & Eyles, D. W. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02005-w · Cited by 18
Joo, Y., Kim, J., Son, Y., Kim, H.-K., Shin, Y.-J., Lee, S.-Y., & Kim, J. (2017) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-017-0821-y · Cited by 14
Managing the Prodrome of Schizophrenia
Fleischhacker, W. W., & Simma, A. M. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25761-2_5 · Cited by 14
Imaging as Tool to Investigate Psychoses and Antipsychotics
Booij, J., & van Amelsvoort, T. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25761-2_12 · Cited by 16
Yamamoto, Y., Takahata, K., Kubota, M., Takano, H., Takeuchi, H., Kimura, Y., Sano, Y., Kurose, S., Ito, H., Mimura, M., et al. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.117543 · Cited by 15
Gee, A., Dazzan, P., Grace, A. A., & Modinos, G. (2025) · Translational Psychiatry · doi:10.1038/s41398-024-03221-2 · Cited by 15
High schizotypy traits are associated with reduced hippocampal resting state functional connectivity
Kozhuharova, P., Saviola, F., Diaconescu, A. O., & Allen, P. (2020) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2020.111215 · Cited by 14
Altered purinergic receptor expression in the frontal cortex in schizophrenia
Alnafisah, R. S., Lundh, A., Asah, S. M., Hoeflinger, J., Wolfinger, A., Hamoud, A.-R. A., McCullumsmith, R. E., & O'Donovan, S. M. (2022) · Schizophrenia · doi:10.1038/s41537-022-00312-1 · Cited by 15
Dahoun, T., Pardiñas, A. F., Veronese, M., Bloomfield, M., Jauhar, S., Bonoldi, I., Froudist‐Walsh, S., Nosarti, C., Korth, C., Hennah, W., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy242 · Cited by 14
Self-citationRogdaki, M., Hathway, P., Gudbrandsen, M., McCutcheon, R. A., Jauhar, S., Daly, E., & Howes, O. D. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.09.005 · Cited by 14
Self-citationStem Cells for Improving the Treatment of Neurodevelopmental Disorders
Donegan, J. J., & Lodge, D. J. (2020) · Stem Cells and Development · doi:10.1089/scd.2019.0265 · Cited by 14
Bortz, D. M., & Grace, A. A. (2018) · Schizophrenia · doi:10.1038/s41537-018-0059-3 · Cited by 12
Lane, N. M., Hunter, S. A., & Lawrie, S. M. (2020) · NeuroImage: Clinical · doi:10.1016/j.nicl.2020.102228 · Cited by 11
Psychosis of Epilepsy: An Update on Clinical Classification and Mechanism
Qiu, Z., Guo, J., Chen, B., & Fang, J. (2025) · Biomolecules · doi:10.3390/biom15010056 · Cited by 18
Sivaraman, S., Kraguljac, N. V., White, D. M., Morgan, C. J., Gonzales, S. S., & Lahti, A. C. (2018) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2018.06.003 · Cited by 11
Torres‐Carmona, E., Nakajima, S., Iwata, Y., Ueno, F., Stefan, C., Song, J., Abdolizadeh, A., KOIZUMI, M., Kambari, Y., Amaev, A., et al. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.06.020 · Cited by 13
Johnsen, E., Hugdahl, K., Fusar‐Poli, P., Kroken, R. A., & Kompus, K. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.147 · Cited by 14
Hengartner, M. P., & Moncrieff, J. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00174 · Cited by 16
Kotowicz, K., Frydecka, D., Gawęda, Ł., Prochwicz, K., Kłosowska, J., Rymaszewska, J., Samochowiec, A., Samochowiec, J., Szczygieł, K., Pawlak, E., et al. (2019) · Early Intervention in Psychiatry · doi:10.1111/eip.12925 · Cited by 11
Predictors of longer-term outcome in the Vienna omega-3 high-risk study
Mossaheb, N., Schäfer, M. R., Schlögelhofer, M., Klier, C. M., Smesny, S., McGorry, P. D., Berger, M., & Amminger, G. P. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.08.010 · Cited by 11
Opportunities in precision psychiatry using PET neuroimaging in psychosis
Coughlin, J. M., Horti, A. G., & Pomper, M. G. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.03.016 · Cited by 13
Towards clinically useful neuroimaging in psychiatric practice
Cooper, D., Limet, N., McClung, I., & Lawrie, S. M. (2013) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.113.126508 · Cited by 11
Ricci, V., Sarni, A., Martinotti, G., & Maina, G. (2025) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2025.104725 · Cited by 12
Giacomel, A., Martins, D., Nordio, G., Easmin, R., Howes, O. D., Selvaggi, P., Williams, S., Turkheimer, F., de Groot, M., Dipasquale, O., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-02938-w · Cited by 16
Self-citationPionke‐Ubych, R., Frydecka, D., Cechnicki, A., Krężołek, M., Nelson, B., & Gawęda, Ł. (2021) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-021-01355-8 · Cited by 14
Tyrosine hydroxylase localization in the nucleus accumbens in schizophrenia
McCollum, L. A., McCullumsmith, R. E., & Roberts, R. C. (2016) · Brain Structure and Function · doi:10.1007/s00429-015-1174-9 · Cited by 12
Bonsall, D. R., Kokkinou, M., Veronese, M., Coello, C. S., Wells, L. A., & Howes, O. D. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14223 · Cited by 8
Self-citationPerez, S. M., Reiley, H. B., & Lodge, D. J. (2022) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgac067 · Cited by 9
NMDAR dysfunction and the regulation of dopaminergic transmission in schizophrenia
Dwyer, G. E., Johnsen, E., & Hugdahl, K. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.07.025 · Cited by 11
Schifani, C., Hafizi, S., Silva, T. M. S., Watts, J. J., Khan, M. S., & Mizrahi, R. (2017) · International Review of Psychiatry · doi:10.1080/09540261.2017.1396205 · Cited by 12
Jangard, S., Jayaram‐Lindström, N., Isacsson, N. H., Matheson, G. J., Plavén‐Sigray, P., Franck, J., Borg, J., Farde, L., & Červenka, S. (2023) · Addiction · doi:10.1111/add.16144 · Cited by 11
A Review of Potential Neuroimaging Biomarkers of Schizophrenia-Risk
Mamah, D. T. (2023) · Journal of Psychiatry and Brain Science · doi:10.20900/jpbs.20230005 · Cited by 15
Allen, P., Hird, E., Orlov, N. D., Modinos, G., Bossong, M. G., Antoniades, M., Sampson, C., Azis, M., Howes, O. D., Stone, J. M., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01705-z · Cited by 9
Self-citationWong, S. M. Y., Suen, Y. N., Wong, C. W. C., Chan, S. K. W., Hui, C. L. M., Chang, W. C., Lee, E. H. M., Cheng, C. P.-W., Ho, G. C. L., Lo, G. G., et al. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06088-7 · Cited by 10
Self-citationEtiopathogenic Models of Psychosis Spectrum Illnesses Must Resolve Four Key Features
Vinogradov, S., Hamid, A., & Redish, A. D. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.06.024 · Cited by 12
Halff, E. F., Natesan, S., Bonsall, D. R., Veronese, M., Garcia-Hidalgo, A., Kokkinou, M., Tang, S.-P., Riggall, L. J., Gunn, R. N., Irvine, E. E., et al. (2022) · Molecular Imaging · doi:10.1155/2022/4419221 · Cited by 11
Self-citationSchizophrenia-associated changes in neuronal subpopulations in the human midbrain
Alsema, A. M., Puvogel, S., Kracht, L., Webster, M. J., Weickert, C. S., Eggen, B. J. L., & Sommer, I. E. (2024) · Brain · doi:10.1093/brain/awae321 · Cited by 10
Rogeau, A., Boer, A. J., Guedj, É., Sala, A., Sommer, I. E., Veronese, M., van der Weijden-Germann, M., Weehaeghe, D. V., Cecchin, D., Verger, A., et al. (2024) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-024-06987-1 · Cited by 11
Srivastav, S., Cui, X., Varela, R. B., Kesby, J. P., & Eyles, D. W. (2023) · Schizophrenia · doi:10.1038/s41537-023-00397-2 · Cited by 11
Neurobiochemical Disturbances in Psychosis and their Implications for Therapeutic Intervention
Panov, G., & Panova, P. (2024) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266282773240116073618 · Cited by 10
Implementing MR Imaging into Clinical Routine Screening in Patients with Psychosis?
Schmidt, A., & Borgwardt, S. (2019) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2019.09.004 · Cited by 10
Attademo, L., Bernardini, F., & Verdolini, N. (2021) · Current Medical Imaging Formerly Current Medical Imaging Reviews · doi:10.2174/1573405617666210114142206 · Cited by 8
Animal Models of Relevance to the Schizophrenia Prodrome
Petty, A. E., Howes, O. D., & Eyles, D. W. (2021) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2021.12.001 · Cited by 8
Self-citationTagliabue, E., Pouvreau, T., Eybrard, S., Meyer, F., & Louilot, A. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.08.021 · Cited by 8
Dopamine dysfunction in schizophrenia
Abi‐Dargham, A. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.09.069 · Cited by 9
Rudin, D., Luethi, D., Niello, M., Yang, J., Burger, I., Sandtner, W., Birner‐Gruenberger, R., Schütz, G. J., & Sitte, H. H. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03201-y · Cited by 15
de Beer, F., de Vries, E. F. J., Wijnen, B. F. M., Begemann, M., van Beveren, N. J. M., Boonstra, N., Gangadin, S. S., de Haan, L., Hamers, I. M. H., Veling, W., et al. (2025) · Psychological Medicine · doi:10.1017/s003329172510161x · Cited by 8
Howes, O. D., Vano, L. J., Petty, A. E., Rutigliano, G., Halff, E. F., Veronese, M., Kaar, S. J., Nordio, G., Lopes, E. F., Cragg, S. J., et al. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2025.10.013 · Cited by 9
Self-citationPsychosis in Huntington's disease: a review and comparison with schizophrenia
Badenoch, J., Rickards, H. E., McCutcheon, R. A., & Nair, A. (2025) · Schizophrenia Research · doi:10.1016/j.schres.2025.07.012 · Cited by 7
Is clinical intervention in the ultra high risk phase effective?
McGuire, P. K., Selvaraj, S., & Howes, O. D. (2011) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462011000600004 · Cited by 8
Self-citationPetty, A. E., Cui, X., Ali, A. A., Du, Z., Srivastav, S., Kesby, J. P., Kirik, D., Howes, O. D., & Eyles, D. W. (2021) · Scientific Reports · doi:10.1038/s41598-021-83681-4 · Cited by 7
Self-citationPresynaptic Dopaminergic Function: Implications for Understanding Treatment Response in Psychosis
Bonoldi, I., & Howes, O. D. (2014) · CNS Drugs · doi:10.1007/s40263-014-0177-z · Cited by 9
Self-citationDelusions: Understanding the Un-understandable
McKenna, P. J. (2017) · Cited by 6
Bhardwaj, S. K., Cui, Q., Moquin, L., Gratton, A. P., Giros, B., & Srivastava, L. K. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108440 · Cited by 6
Visual contrast sensitivity in clinical high risk and first episode psychosis
Kadivar, A., Ilapakurti, M., Dobkins, K. R., & Cadenhead, K. S. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.07.019 · Cited by 6
Early Detection of Psychosis: Challenges and Opportunities
Gur, R. E. (2014) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-014-0012-3 · Cited by 6
The early identification of psychosis: can lessons be learnt from cardiac stress testing?
Gupta, S., Ranganathan, M., & D’Souza, D. C. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4143-3 · Cited by 7
Neuroimaging studies in people at clinical high risk for psychosis
Gifford, G., McCutcheon, R. A., & McGuire, P. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813201-2.00009-0 · Cited by 8
Self-citationFunctional Dysconnectivity in Ventral Striatocortical Systems in 22q11.2 Deletion Syndrome
Tepper, Á., Cuiza, A., Alliende, L. M., Mena, C., Ramírez-Mahaluf, J. P., Iruretagoyena, B., Ornstein, C., Fritsch, R., Nachar, R., González‐Valderrama, A., et al. (2021) · Schizophrenia Bulletin · doi:10.1093/schbul/sbab139 · Cited by 6
Dopamine: A Marker of Psychosis and Final Common Driver of Schizophrenia Psychosis
Henn, F. A. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11091346 · Cited by 6
Targeting the Roots of Psychosis: The Role of Aberrant Salience
Marano, G., Lisci, F. M., Sfratta, G., Marzo, E. M., Abate, F., Boggio, G., Traversi, G., Mazza, O., Pola, R., Gaetani, E., et al. (2025) · Pediatric Reports · doi:10.3390/pediatric17030063 · Cited by 8
Does human presynaptic striatal dopamine function predict social conformity?
Stokes, P. R. A., Benecke, A., Puraite, J., Bloomfield, M., Shotbolt, P., Reeves, S., Lingford-Hughes, A. R., Howes, O. D., & Egerton, A. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113512037 · Cited by 5
Self-citationSestito, M., Parnas, J., Maggini, C., & Gallese, V. (2017) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2017.00269 · Cited by 6
Xu, D., Wei, L., Li, H., & Zhang, W. J. (2019) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12026 · Cited by 5
Margariti, M. M., & Vlachos, I. I. (2022) · Medical Hypotheses · doi:10.1016/j.mehy.2022.110915 · Cited by 6
Maternal Nutritional Deficiencies and Schizophrenia
Eyles, D. W., & Dean, A. J. (2015) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-800981-9.00015-8 · Cited by 4
Reinventing schizophrenia: The rules of the game
McCutcheon, R. A., & McGuire, P. K. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2021.12.009 · Cited by 5
Self-citationLambert, M., & Correll, C. U. (2015) · Der Nervenarzt · doi:10.1007/s00115-015-4427-1 · Cited by 4
Hayat, T. T. A., & Sami, M. B. (2020) · Development and Psychopathology · doi:10.1017/s0954579420000218 · Cited by 2
DSM-5: ¿SÍNDROME DE PSICOSIS ATENUADA?
Fonseca‐Pedrero, E., Paíno, M., & Fraguas, D. (2013) · Repositorio de la Universidad de Oviedo (RUO) · Cited by 10
Early Identification of Psychiatric Disorders
Lee, T. Y., Kim, M., & Kwon, J. S. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9721-0_18 · Cited by 6
Neurochemical models of psychosis risk and onset
Oliver, D., Modinos, G., & McGuire, P. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813201-2.00012-0 · Cited by 4
Self-citationSonego, A. B., Prado, D. D. S., Uliana, D. L., Cunha, T. M., Grace, A. A., & Resstel, L. B. M. (2024) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2024.09.001 · Cited by 4
Matheson, G. J., Plavén‐Sigray, P., Louzolo, A., Borg, J., Farde, L., Petrović, P., & Červenka, S. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.06.001 · Cited by 5
Abayomi, O., Amato, D., Bailey, C. C., Bitanihirwe, B. K. Y., Bowen, L., Burshtein, S., Cullen, A. E., Fusté, M., Herrmann, A. P., Khodaie, B., et al. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.08.032 · Cited by 6
Digital data repository and automatic analysis framework for FDOPA PET neuroimagingPreprint
Nordio, G., Easmin, R., Giacomel, A., Dipasquale, O., Martins, D., Williams, S., Turkheimer, F., Howes, O. D., & Veronese, M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.14.488129 · Cited by 3
Self-citationRefining mechanistic models of hallucinations for enhanced translatability
Buck, J., Iigaya, K., & Horga, G. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03773-x · Cited by 2
The utility of PET imaging in the diagnosis and management of psychosis: a brief review
Rigney, G. H., Ayubcha, C., Werner, T. J., Alavi, A. A., & Revheim, M.-E. R. (2021) · Clinical and Translational Imaging · doi:10.1007/s40336-021-00466-5 · Cited by 2
Nestor, P. G., Levin, L. K., Stone, W. S., Giuliano, A. J., Seidman, L. J., & Levitt, J. J. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.08.027 · Cited by 2
Iseli, G. C., Ulrich, S., & Schmidt, A. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1098019 · Cited by 2
Increasing the Interpretability of Psychosis Models
Buck, J., & Horga, G. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.10.022 · Cited by 2
Naasan, G. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800105-9.00023-8 · Cited by 2
Neuroimaging and the At-Risk Mental State
Lin, Y.-S., Fusar‐Poli, P., & Borgwardt, S. (2019) · Springer eBooks · doi:10.1007/978-3-319-97307-4_6 · Cited by 2
Clozapine but not lithium reverses aberrant tyrosine uptake in patients with bipolar disorder
Tabrisi, R., Harun-Rashid, M., Montero, J., Venizelos, N., & Msghina, M. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06397-5 · Cited by 2
Lambert, M., & Correll, C. U. (2016) · Der Nervenarzt · doi:10.1007/s00115-015-0055-z · Cited by 2
Should a ‘psychosis risk syndrome’ be a separate diagnosis in DSM-5?
Fleischhacker, W. W., & DeLisi, L. E. (2012) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3283535921 · Cited by 3
Kokkinou, M., Irvine, E. E., Bonsall, D. R., Natesan, S., Wells, L. A., Smith, M., Glegola, J. A., Paul, E. J., Tossell, K., Veronese, M., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/748665 · Cited by 2
Self-citationChen, E. Y. H., Wong, S. M. Y., So, M. M., Suen, Y. N., & Hui, C. L. M. (2025) · Psychological Medicine · doi:10.1017/s0033291724003027 · Cited by 2
Hamati, R., Kanaa, N., Chidiac, B., Guimond, S., Cassidy, C., & Tuominen, L. J. (2026) · Schizophrenia · doi:10.1038/s41537-026-00731-4 · Cited by 1
18F-fluorodeoxyglucose PET in Major Psychiatric Disorders
Ferrando, R., & Coutinho, A. M. (2026) · PET Clinics · doi:10.1016/j.cpet.2026.05.007 · Cited by 1
PET and SPECT in Personality Disorders
Pérez-Rodríguez, M. M., Ripoll, L. H., Siever, L. J., & New, A. S. (2014) · Springer eBooks · doi:10.1007/978-3-642-40384-2_21 · Cited by 3
Metadata
- Authors
- Howes, O. D., Bose, S. K., Turkheimer, F., Valli, I., Egerton, A., Valmaggia, L. R., Murray, R. M., & McGuire, P.
- Affiliations
- King's College London (GB)
- ORCID
- Venue
- American Journal of Psychiatry
- Published
- 2011-12
- Volume
- 168
- Issue
- 12
- Pages
- 1311-1317
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- PMC
- PMC3682447
- OpenAlex
- W2143870537
- Cited by
- 343
- References
- 40
- Citations by year
- 2026: 11 · 2025: 13 · 2024: 16 · 2023: 17 · 2022: 24 · 2021: 17 · 2020: 29 · 2019: 30 · 2018: 20 · 2017: 22 · 2016: 37 · 2015: 21 · 2014: 27 · 2013: 31 · 2012: 26
- FWCI
- 18.93
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- South London and Maudsley NHS Foundation Trust
- Medical Research Council
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- dopamine synthesis capacity, clinical high risk for psychosis, first-episode psychosis, striatum, 18F-DOPA PET, symptom severity, schizophrenia, schizotypal personality disorder
- MeSH terms
- Adult, Brain, Corpus Striatum, Dopamine, Female, Humans, Male, Prospective Studies, Psychotic Disorders, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.